Workflow
威高血净: 山东威高血液净化制品股份有限公司第二届董事会第十三次会议决议公告

Meeting Overview - The second meeting of the board of directors of Shandong Weigao Blood Purification Products Co., Ltd. was held on August 26, 2025, with all 9 directors present [1][2]. Resolutions Passed - The board approved the full and summary reports for the 2025 semi-annual report [2][6]. - The board approved the proposal for the 2025 interim dividend distribution, which will be submitted to the shareholders' meeting for review [2][3]. - The board approved the draft of the 2025 Restricted Stock Incentive Plan and its summary, which will also be submitted to the shareholders' meeting [2][3]. - The board approved the implementation assessment management measures for the 2025 Restricted Stock Incentive Plan, requiring submission to the shareholders' meeting [3][4]. - The board proposed to authorize the board to handle matters related to the 2025 Restricted Stock Incentive Plan, which includes determining eligibility and conditions for participants [4][5]. - The board approved a special report on the management and actual use of raised funds for the first half of 2025 [6][7]. - The board approved the cancellation of the supervisory board and changes to the company's business scope, which will be submitted to the shareholders' meeting [6][7]. - The board approved the nomination of Zhang Zhenhua as an independent director candidate, with an annual allowance of RMB 150,000 [7][8]. - The board proposed to convene the first extraordinary shareholders' meeting of 2025 [7].